$590.00▴ 0.89%
End-of-day close · 2026-08-06
What most investors miss
Trends, drivers and alerts — the full picture.
Profit → Cash
Not enough data yet
Valuation
26th pctvs its own history
Cheap
Its valuation sits in the cheaper end of its own recent range.
Revenue growth
Not enough data yet
Not enough revenue history to measure growth.
Leverage
Not enough data yet
Term-debt data is not available for this company.
More coming: dilution / share-count creep.
Fair value
Overvalued
Trading about 29% above our fair-value range
A cash-flow (DCF) estimate cross-checked against peer multiples.
✦ The read
IDEXX Laboratories, Inc.'s earnings-quality signal is not available yet. Its valuation sits in the cheaper end of its own recent range.
Key numbers
Valuation
EPS (TTM)$14.23
TTM (trailing 12 months, through fiscal Q2 FY2026)
Profitability
Net margin25.0%
TTM (trailing 12 months, through fiscal Q2 FY2026)
Size
Revenue (TTM)$4.55B
TTM (trailing 12 months, through fiscal Q2 FY2026)
Recent news
Sentiment · last 30 days2 articles
1 bullish1 neutral0 bearish
Signals and key numbers are from the fiscal Q2 FY2026 filing. Price freshness: end-of-day close on Free, 15-min delayed on Pro.